NEULAND LAB LTD. (NEULANDLAB) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

Neuland Laboratories is engaged in manufacturing and selling of bulk drugs and caters to both domestic and international markets.[1]

NEULANDLABUpdated 25 Jul 2026, 10:07

Neuland Lab Ltd.

Market Cap

₹23,794Cr.

Current Price

₹18,546

High / Low

₹20,089/11,500

Stock P/E

66.0

Book Value₹1,454
Dividend Yield0.18%
ROCE26.5%
ROE21.3%
Face Value₹10.0

About

Neuland Laboratories is engaged in manufacturing and selling of bulk drugs and caters to both domestic and international markets.[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days1008511413490918590111877898
Inventory Days170182188268191209205227211220238245
Days Payable167124123198123114130105135125161134
Cash Conversion Cycle103144179205158186160212187183155209
Working Capital Days9244236136135597278877474
ROCE %16%18%16%4%4%8%11%10%21%33%19%27%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 25 July 2026 at 10:07


Designed & Shipped by Harshit Bansal